EUVIMEDEUVIMED entdecken
Systematische Übersicht

Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review

Sajjad Samieefar, Omid Arasteh, Negar Yeganeh Khorasanii, Farshad Abedi, Hamid Reza Hosseinzadeh, Hossein Hosseinzadeh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-05 · 399 (8) · 11055-11071

DOI: 10.1007/s00210-026-05120-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 20.02.2026. Verfasst von Sajjad Samieefar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran. Hauptthemen laut MEDLINE: Melanoma, Immune Checkpoint Inhibitors, Skin Neoplasms, Biological Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, the most lethal form of skin cancer, poses significant therapeutic challenges despite advances in immunotherapy. Natural compounds have emerged as promising adjuncts for modulating immune checkpoint pathways, including PD-1/PD-L1, CTLA-4, and LAG-3. A systematic review was conducted from inception to July 2025, searching the Web of Science, PubMed/MEDLINE, and Scopus. MeSH terms and keywords encompassed immune checkpoints, natural compounds (e.g., phytochemicals), and melanoma. We included original studies investigating natural compounds in melanoma models that reported outcomes related to immune checkpoint modulation. Nineteen preclinical studies met the inclusion criteria. Flavonoids (quercetin, apigenin, and luteolin) inhibited PD-L1 via JAK2/STAT3 and IFN-γ/STAT1 suppression. Emerging bioactive sources such as Polygonum minus and drimenol were identified as multi-target agents capable of reprogramming the tumor microenvironment. Alkaloids such as berberine promoted PD-L1 degradation through the CSN5-ubiquitin-proteasome axis. Nanocarrier-based delivery systems, particularly calcium carbonate nanoparticles, enhanced bioavailability and achieved synergistic efficacy with reduced systemic toxicity, highlighting a key strategy for clinical translation. Natural compounds offer a multi-targeted strategy to overcome melanoma resistance. While current preclinical evidence is promising, it remains hypothesis-generating. The findings suggest that phytochemicals can modulate multiple checkpoints with a favorable safety profile. Future research must focus on rigorous clinical trials to establish standardized dosing and validate safety margins for translating these agents into effective personalized melanoma immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaImmune Checkpoint InhibitorsSkin NeoplasmsBiological ProductsHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

Immune checkpoint inhibitorsMelanomaNatural compoundsPD-L1Tumor microenvironment

Substanzen

Immune Checkpoint InhibitorsBiological Products

Autor:innen und Institutionen

  • Student Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran.
  • Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran.
  • Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran. hosseinzadehh@mums.ac.ir.
  • Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Islamic Republic of Iran. hosseinzadehh@mums.ac.ir.

Zitieren

APA

Samieefar, S., Arasteh, O., Yeganeh Khorasanii, N., Abedi, F., Hosseinzadeh, H. R., & Hosseinzadeh, H. (2026). Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(8), 11055-11071. https://doi.org/10.1007/s00210-026-05120-3

Vancouver

Samieefar S, Arasteh O, Yeganeh Khorasanii N, Abedi F, Hosseinzadeh HR, Hosseinzadeh H. Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(8):11055-11071. doi:10.1007/s00210-026-05120-3

BibTeX
@article{Samieefar2026,
  author = {Samieefar, Sajjad and Arasteh, Omid and Yeganeh Khorasanii, Negar and Abedi, Farshad and Hosseinzadeh, Hamid Reza and Hosseinzadeh, Hossein},
  title = {Natural compounds as immune checkpoint inhibitors in melanoma: a systematic review},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {8},
  pages = {11055--11071},
  doi = {10.1007/s00210-026-05120-3}
}
Kostenlos starten →